Gholamreza Karimi Selected Research

Heart Diseases (Heart Disease)

3/2019	The protective activity of nanomicelle curcumin in bisphenol A-induced cardiotoxicity following subacute exposure in rats.
1/2012	Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gholamreza Karimi Research Topics

Disease

33	Neoplasms (Cancer) 08/2023 - 01/2010
27	Inflammation (Inflammations) 10/2023 - 11/2010
20	Cardiotoxicity 10/2023 - 10/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 05/2016
6	Wounds and Injuries (Trauma) 05/2023 - 04/2017
6	Hypertension (High Blood Pressure) 01/2023 - 10/2018
6	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2016
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 12/2016
4	Dyslipidemias (Dyslipidemia) 01/2023 - 10/2018
4	Hypoxia (Hypoxemia) 01/2023 - 06/2011
4	Atherosclerosis 01/2023 - 11/2010
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 06/2017
4	Insulin Resistance 11/2021 - 07/2017
4	Heart Failure 01/2021 - 06/2011
4	Poisoning 01/2021 - 06/2011
4	Necrosis 11/2020 - 09/2005
4	Hypersensitivity (Allergy) 12/2018 - 09/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 08/2021
3	Nervous System Diseases (Neurological Disorders) 10/2023 - 01/2023
3	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2017
3	Reperfusion Injury 01/2023 - 12/2016
3	Pain (Aches) 09/2022 - 03/2010
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 06/2017
3	Cardiac Arrhythmias (Arrythmia) 01/2021 - 06/2011
3	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 09/2017
3	Carcinogenesis 12/2020 - 02/2014
3	Neuralgia (Stump Neuralgia) 11/2020 - 03/2010
3	Hypertrophy 12/2019 - 06/2017
2	Drug-Related Side Effects and Adverse Reactions 04/2024 - 01/2021
2	COVID-19 01/2024 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2023 - 01/2023
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2023 - 09/2022
2	Multiple Sclerosis 06/2023 - 05/2019
2	Obesity 01/2023 - 11/2021
2	Pathologic Processes 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

14	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 10/2005
13	SilymarinIBA 06/2022 - 09/2005
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2014
11	Sirtuin 1IBA 10/2023 - 06/2017
11	MicroRNAs (MicroRNA)IBA 02/2023 - 01/2016
9	ArsenicIBA 10/2023 - 11/2015
9	LipidsIBA 01/2023 - 07/2014
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 05/2011
7	AntioxidantsIBA 01/2022 - 07/2011
6	SirtuinsIBA 01/2023 - 01/2018
6	InterleukinsIBA 01/2023 - 07/2015
6	CytokinesIBA 12/2018 - 11/2010
5	MelatoninIBA 05/2023 - 12/2020
5	Free RadicalsIBA 12/2022 - 10/2005
5	Therapeutic UsesIBA 09/2022 - 10/2018
4	EnzymesIBA 12/2023 - 01/2012
4	Glutathione (Reduced Glutathione)IBA 01/2023 - 03/2019
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2022
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 01/2006
4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 09/2005
4	Blood Glucose (Blood Sugar)IBA 01/2023 - 06/2017
4	crocinIBA 01/2020 - 07/2013
3	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 12/2023 - 08/2021
3	Superoxide DismutaseIBA 01/2023 - 11/2022
3	AMP-Activated Protein KinasesIBA 01/2023 - 01/2022
3	ResveratrolIBA 01/2023 - 05/2017
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2023 - 05/2018
3	Mitogen-Activated Protein KinasesIBA 01/2023 - 11/2022
3	NF-kappa B (NF-kB)IBA 01/2023 - 10/2021
3	auraptenIBA 12/2022 - 01/2010
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2022 - 09/2017
3	resolvin D1IBA 09/2022 - 01/2021
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2022 - 07/2015
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 11/2015
3	InflammasomesIBA 10/2021 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
3	CurcuminIBA 01/2021 - 05/2011
3	Glucosamine (Dona)IBA 11/2017 - 07/2014
2	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2021
2	Caspase 3 (Caspase-3)IBA 12/2023 - 07/2022
2	Dacarbazine (DIC)FDA LinkGeneric 10/2023 - 03/2022
2	MycotoxinsIBA 08/2023 - 02/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023 - 01/2018
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2023
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023 - 03/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2016
2	Protein Kinases (Protein Kinase)IBA 01/2023 - 01/2023
2	Troponin IIBA 01/2023 - 09/2018
2	CalcineurinIBA 01/2023 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2023
2	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 09/2018
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2023 - 01/2023
2	C-Reactive ProteinIBA 01/2023 - 01/2023
2	Heme Oxygenase-1IBA 01/2023 - 01/2022
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023 - 11/2022
2	Malondialdehyde (Propanedial)IBA 01/2023 - 03/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023 - 05/2019
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2023 - 01/2023
2	arginine methyl esterIBA 01/2023 - 03/2010
2	HDL LipoproteinsIBA 01/2023 - 11/2022
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2023 - 03/2010
2	oxidized low density lipoproteinIBA 01/2023 - 07/2015
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 07/2015

Therapy/Procedure

10	Therapeutics 01/2024 - 03/2010
8	Drug Therapy (Chemotherapy) 06/2022 - 06/2016